At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02595 GENFLEET-B
Not Yet Opened 07-27 16:08:04
33.180
-1.640
-4.71%
High35.020Low32.560Vol822.85K
Open34.700D1 Closing34.820Amplitude7.06%
Mkt Cap12.74BTradable Cap11.68BTotal Shares384.00M
T/O27.52MT/O Rate0.23%Tradable Shares352.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜GenFleet Therapeutics-B Rises 5.76% in Regular Trading, Technical Recovery Following H-Share Placement Completion
Market Focus  ·  07-21
Movement Alert｜GenFleet Therapeutics-B Rises 5.76% in Regular Trading, Technical Recovery Following H-Share Placement Completion
Wellington Management Group LLP Boosts Stake in GENFLEET-B with Share Purchase
Stock News  ·  07-17
Wellington Management Group LLP Boosts Stake in GENFLEET-B with Share Purchase
GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure
Bulletin Express  ·  07-17
GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure
GENFLEET-B Successfully Places 13.6 Million Shares, Raising Approximately HK$467 Million Net
Stock News  ·  07-17
GENFLEET-B Successfully Places 13.6 Million Shares, Raising Approximately HK$467 Million Net
Genfleet Therapeutics Completes Placement of 13,600,000 New H Shares at HK$ 34.69 Each
Reuters  ·  07-17
Genfleet Therapeutics Completes Placement of 13,600,000 New H Shares at HK$ 34.69 Each
Movement Alert｜GenFleet Therapeutics-B Declines 8.2% in Regular Trading, Biotech Sector Under Broad Pressure After Prior Rally
Market Focus  ·  07-17
Movement Alert｜GenFleet Therapeutics-B Declines 8.2% in Regular Trading, Biotech Sector Under Broad Pressure After Prior Rally
GenFleet Therapeutics Seeks HK$467 Million via H-Share Placement; Shares Up 11%
MT Newswires Live  ·  07-15
GenFleet Therapeutics Seeks HK$467 Million via H-Share Placement; Shares Up 11%
GENFLEET-B Announces Private Placement of 13.6 Million Shares at Approximately 9.71% Discount, Raising Net Proceeds of HK$467 Million
Stock News  ·  07-15
GENFLEET-B Announces Private Placement of 13.6 Million Shares at Approximately 9.71% Discount, Raising Net Proceeds of HK$467 Million
Genfleet Therapeutics Prices 13,600,000-share H-share Placement at HK$ 34.69 Each
Reuters  ·  07-15
Genfleet Therapeutics Prices 13,600,000-share H-share Placement at HK$ 34.69 Each
Genfleet Therapeutics (shanghai) - Gross Proceeds from Placing Hk$471.8 Mln; Net Proceeds Estimated at Hk$466.9 Mln
THOMSON REUTERS  ·  07-15
Genfleet Therapeutics (shanghai) - Gross Proceeds from Placing Hk$471.8 Mln; Net Proceeds Estimated at Hk$466.9 Mln
Genfleet Therapeutics (shanghai) - to Place 13.6 Mln New H Shares at Hk$34.69 Per Share
THOMSON REUTERS  ·  07-15
Genfleet Therapeutics (shanghai) - to Place 13.6 Mln New H Shares at Hk$34.69 Per Share
Wellington Management Trims Stake in GENFLEET-B by Approximately 351,600 Shares
Stock News  ·  07-08
Wellington Management Trims Stake in GENFLEET-B by Approximately 351,600 Shares
GenFleet-B Maintains Stable Share Base and Meets Public Float Requirement in June 2026 Monthly Return
Bulletin Express  ·  07-06
GenFleet-B Maintains Stable Share Base and Meets Public Float Requirement in June 2026 Monthly Return
Genfleet Therapeutics (shanghai) Approves H Share Repurchase up to Hk$350 Million
Reuters  ·  06-29
Genfleet Therapeutics (shanghai) Approves H Share Repurchase up to Hk$350 Million
GenFleet Therapeutics Launches Share Buyback
MT Newswires Live  ·  06-29
GenFleet Therapeutics Launches Share Buyback
GENFLEET-B Surges Over 15% in Afternoon Trading as Bank of Communications International Reiterates "Buy" Rating
Deep News  ·  06-29
GENFLEET-B Surges Over 15% in Afternoon Trading as Bank of Communications International Reiterates "Buy" Rating
Genfleet Therapeutics (shanghai) - Approves H Share Repurchase up to Hk$350 Mln on Open Market
THOMSON REUTERS  ·  06-29
Genfleet Therapeutics (shanghai) - Approves H Share Repurchase up to Hk$350 Mln on Open Market
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)
TIPRANKS  ·  06-28
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)
Bocom International Reiterates 'Buy' on GENFLEET-B with HK$58 Target Price
Stock News  ·  06-25
Bocom International Reiterates 'Buy' on GENFLEET-B with HK$58 Target Price
From Doubling to Halving: The Rollercoaster Ride of GENFLEET-B's Share Price
Stock News  ·  06-17
From Doubling to Halving: The Rollercoaster Ride of GENFLEET-B's Share Price

Introduction

Company Name.
GENFLEET-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
GenFleet Therapeutics (Shanghai) Inc is a China-based company principally engaged in the development of innovative drugs. The Company provides effective new treatment solutions for tumors, autoimmune and inflammatory diseases, covering target discovery, molecular discovery and evaluation, translational science and clinical development, as well as key chemistry manufacturing and controls aspects including formulation research, process development and quality analysis. The Company is mainly engaged in the development of new molecular entities, novel molecular modalities, investigation of molecular process routes and quality standards, and exploration of differentiated clinical development strategies and paths. The Company mainly primarily operates in the domestic and international markets.
Issue price:
--